Topical 5% tranexamic acid for the treatment of melasma in Asians: a double-blind randomized controlled clinical trial.
randomized, double-blind
EVIDENCE COMPARISON
DirectionalEarly or indirect evidence suggests tranexamic acid may reduce skin tone redness twelve times more effectively than oxymetazoline hydrochloride based on indirect comparison.
Effect ratio
Favored
Studies
Comparison
This is an indirect comparison — the two ingredients were not tested head-to-head in the same trial. The ratio is derived from separate studies against a common comparator.
Tone
Kept public as exploratory because it indirect comparison; includes estimated measurement; early-stage evidence tier.
Some study-specific context may affect how broadly this comparison generalizes.